SuperworthHarmony Biosciences profit margin HRMY
Gross, operating and net profit as a share of revenue over the last twelve months, from 2020.
- Net margin, 12 months
- 18.9%
- Operating margin, 12 months
- 24.0%
- Net margin on a year earlier
- −4.5 pts
- Peer median
- 8.8%
Over the twelve months to Jun 30, 2026, Harmony Biosciences kept 18.9% of its revenue as net profit, with an operating margin of 24.0% and a gross margin of 75.4%.
Five years earlier its net margin was 9.9%.
The median for 10 large drugmakers of a similar size is 8.8%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | 18.3% | 24.0% | 77.2% |
| FY2024 | 20.4% | 26.7% | 78.1% |
| FY2023 | 22.1% | 33.0% | 79.2% |
| FY2022 | 41.4% | 27.4% | 80.9% |
| FY2021 | 11.3% | 28.7% | 81.8% |
| FY2020 | −23.1% | 9.9% | 82.6% |
| FY2019 | n/a | n/a | n/a |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | 18.9% | −4.5 pts | 24.0% | |
| Q1 FY26 | 16.2% | −4.3 pts | 21.1% | |
| Q4 FY25 | 18.3% | −2.1 pts | 24.0% | |
| Q3 FY25 | 22.5% | +4.5 pts | 27.3% | |
| Q2 FY25 | 23.4% | +5.9 pts | 28.7% | |
| Q1 FY25 | 20.5% | −1.8 pts | 26.2% | |
| Q4 FY24 | 20.4% | −1.8 pts | 26.7% | |
| Q3 FY24 | 18.0% | −9.8 pts | 25.7% | |
| Q2 FY24 | 17.5% | −22.6 pts | 27.1% | |
| Q1 FY24 | 22.3% | −17.9 pts | 33.0% | |
| Q4 FY23 | 22.1% | −19.3 pts | 33.0% | |
| Q3 FY23 | 27.8% | −11.0 pts | 36.8% |
Against its peers
Companies in Drug Manufacturers - General nearest Harmony Biosciences' size, closest first, today.
| Company | Profit margin |
|---|---|
| HRMYHarmony Biosciences | 18.9% |
| PBHPrestige Consumer Healthcare | 15.6% |
| ANIPANI Pharmaceuticals | 11.1% |
| NRIXNurix Therapeutics | 42.0% |
| PAHCPhibro Animal Health | 6.6% |
| ANABAnaptysbio | n/m |
| PCRXPacira BioSciences | 2.0% |
| OGNOrganon | 3.4% |
| OMEROmeros | n/m |
| LQDALiquidia | 30.7% |
| ARQTArcutis Biotherapeutics | 6.1% |
| Peer median | 8.8% |
Where Harmony Biosciences ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Harmony Biosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.